improve News newsbot.ch

Eidgenössisches Departement für Auswärtige Angelegenheiten »

Virtual High-Level Forum: “The UN Charter at 75: Multilateralism in a Fragmented World” (en)

2020-06-10 15:52:05


Europäische Kommission »

Shaping Europe's digital future: Eurobarometer survey shows support for sustainability and data sharing

2020-03-05 16:25:01


»

Datenschutz und Rechtliches

2020-02-06 13:40:18


Europäische Kommission »

Commission welcomes provisional agreement to improve the quality of drinking water and the access to it

2019-12-19 20:25:04


Europäische Kommission »

First Juncker Plan project in Malta brings broadband to 70,000 homes

2019-11-28 14:25:00


Kanton Thurgau »

Arbeiten im Thurgau: «Leben statt pendeln»

Arbeiten im Thurgau: «Leben statt pendeln»

2019-11-04 09:32:00


Europäische Kommission »

Daily News 23 / 10 / 2019

2019-10-23 17:25:14


»

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

2019-09-30 19:20:02


»

FDA approves Roche’s Rituxan (rituximab) in children with two rare blood vessel disorders

2019-09-30 07:20:03


»

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

2019-09-27 14:20:09


»

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

2019-09-20 07:40:10


»

Roche’s satralizumab significantly reduced relapse risk in second  positive phase III study for neuromyelitis optica spectrum

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

2019-09-12 13:20:00


»

Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy

2019-09-12 13:20:00


»

Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS

2019-09-10 05:40:12


»

European Commission approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of people with extensive-stage small cell lung cancer

2019-09-06 06:20:00


»

Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS

2019-09-04 06:40:12


»

European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer

2019-08-29 07:40:16


»

FDA approves Roche’s Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours

2019-08-16 16:40:40


»

Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer

2019-08-05 05:40:23


»

Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

2019-07-26 11:20:11



Suchresultate als RSS-Feed